We are delighted to announce the recipients of our new Future of Haematology Grants Programme, launched at the end of 2018. 

This new and innovative funding programme supports professionals still at an early stage in their careers, working with a haematology specialism. 

Following the first call for applicants  for our Future of Haematology Grant Programme last Autumn, we were impressed by the high standard of applications received from across the UK. Our medical panel carefully considered each application and we are delighted to announce the recipients for this round of applications.

We are excited about the projects and initiatives we are funding covering different areas and types of blood cancer care and research. They all have the potential to lead to significant results and we are able to fund our Future of Haematology Grants only thanks to the kind and generous donations from our supporters. 

Dr. Patrick Harrington, MBBS, MRCP, FRCPath, Clinical Research Fellow/Haematology ST7, Guy’s and St Thomas’ NHS Foundation Trust & PhD Student, King’s College London has been awarded a grant for his Chronic myeloid leukaemia project (see video below) and the results from this research may lead to identifying new possible treatments for this type of blood cancer.

We were pleased to offer funding towards the project proposed by Dr Francesca Kinsella PhD MRCP FRCPathNIHR, Clinical Lecturer in Haematology, Institute of Immunology and Immunotherapy, University of Birmingham. Dr. Kinsella's project is titled: High dimensional analysis of the composition of peripheral blood stem cell donations and the impact on
clinical outcome following allogeneic haemopoietic stem cell transplantation:

Bone marrow transplantation is an effective treatment for many types of blood borne cancers, but the disease will return in half of all patients treated within six to twelve months. Because of this, the search for treatments to prevent the return of leukaemia after bone marrow transplantation is of paramount importance. After a bone marrow transplant it is thought that the new donor immune system kills off the patient’s leukaemia and keeps the disease away, but we do not currently understand exactly how the new donated immune system accomplishes this. Various donor cell types can kill left over cancer cells, while others have been found to dampen down immune reactions and prevent damage to patients’ organs.

The aim of this project is to find the ideal mix of the donor cells transplanted with the stem cells to provide a cure from cancer while making the procedure safer for patients. If this can be understood then clinical trials may be designed to 1- alter the make-up of patients’ transplants to improve their chance of cure; 2 - store specific donor cells to return to patients at a later date should their cancer return, and 3- develop a simpler, cheaper test to provide the same information, so that all patients undergoing transplant might benefit from this more personalised approach.

Surabhi Chaturvedi (BA Hons, MA, MSc), Psychotherapist & Counsellor (BACP Accredited) Haemato-Oncology, King's College Hospital has received a grant to present at the annual conference of the European Society for Blood and Marrow Transplantation (EBMT) in Frankfurt this March.

Watch the video below to find out the difference Surabhi's presentation will make and the significance of her work:

Kathryn Clarke Ph.D, Trainee Clinical Scientist, Haematology and Transfusion, Haematopathology and Oncology Diagnostic Service, Cambridge University Hospitals NHS Foundation was awarded a grant for her project entitled “Immuno-flowFISH” for the assessment of chromosomal abnormalities in chronic lymphocytic leukaemia with deletion 17p. We look forward on reporting the outcomes from this project.

Satyen Gohil from University College London Cancer Institute was awarded a grant towards funding his two year project 'Investigating Mechanisms of resistance to CD19 CAR-T cells using high dimensional single cell technologies'.

We awarded a grant to Haili Cui, Lead Apheresis CNS in King's College Hospital, London. In Haili's own words:

I have been working in haematology clinical setting for more than 14 years in the UK including Haematology inpatient, outpatient and now specialise in Haematology Apheresis. Apheresis Unit has been a nurse led service since 1997 and is an integral part of the Department of Haematology. There have seen a steady increase in the number and range of procedures performed including stem cell harvest, red cell exchange and plasma exchange, donor lymphocyte collections, Car T Cell  leukapheresis procedure.  My daily role is to manage the unit to deliver a high standard and safe care for patients who require Apheresis procedure and provide training for junior staff nurse. 

I am going to perform a poster presentation in EBMT conference in March this year. The title of the presentation is AN UNUSUAL CASE OF DELAYED CITRATE REACTION AFTER PERIPHERAL BLOOD STEM CELL HARVEST. This is a case study which has very rare symptoms of citrate toxicities that was developed half an hour post procedure.

I am very grateful to Leukaemia UK's Grants Programme, which has provided funding for me to attend EBMT. I feel this is very important to present this case study which enables me to share my experiences with other professionals during the conference. Through this poster presentation, I am hoping to increase awareness to monitor patients for changes in their condition post procedure and recognising early clinical deterioration and protection from harm or errors.

We are grateful to all the applicants for helping make a difference to those affected by blood cancer with the aim to provide potential improvements in care or advances towards better treatments. 

Our next round of grants will be announced in April 2019, where we will be calling for further applicants.

If you have any questions or queries about this programme please do not hesitate to contact us on [email protected]